219 related articles for article (PubMed ID: 22932738)
1. Assessment of grating-based X-ray phase-contrast CT for differentiation of invasive ductal carcinoma and ductal carcinoma in situ in an experimental ex vivo set-up.
Sztrókay A; Herzen J; Auweter SD; Liebhardt S; Mayr D; Willner M; Hahn D; Zanette I; Weitkamp T; Hellerhoff K; Pfeiffer F; Reiser MF; Bamberg F
Eur Radiol; 2013 Feb; 23(2):381-7. PubMed ID: 22932738
[TBL] [Abstract][Full Text] [Related]
2. Assessment of intraductal carcinoma in situ (DCIS) using grating-based X-ray phase-contrast CT at conventional X-ray sources: An experimental ex-vivo study.
Hellerhoff K; Birnbacher L; Sztrókay-Gaul A; Grandl S; Auweter S; Willner M; Marschner M; Mayr D; Reiser MF; Pfeiffer F; Herzen J
PLoS One; 2019; 14(1):e0210291. PubMed ID: 30625220
[TBL] [Abstract][Full Text] [Related]
3. X-ray phase-contrast tomosynthesis for improved breast tissue discrimination.
Schleede S; Bech M; Grandl S; Sztrókay A; Herzen J; Mayr D; Stockmar M; Potdevin G; Zanette I; Rack A; Weitkamp T; Pfeiffer F
Eur J Radiol; 2014 Mar; 83(3):531-6. PubMed ID: 24387825
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of breast MRI for surgical decision in patients with breast cancer: ductal carcinoma in situ versus invasive ductal carcinoma.
Lee J; Jung JH; Kim WW; Park CS; Lee RK; Kim HJ; Kim WH; Park HY
BMC Cancer; 2020 Sep; 20(1):934. PubMed ID: 32993586
[TBL] [Abstract][Full Text] [Related]
5. Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS.
Nicholson S; Hanby A; Clements K; Kearins O; Lawrence G; Dodwell D; Bishop H; Thompson A;
Eur J Surg Oncol; 2015 Jan; 41(1):86-93. PubMed ID: 25441934
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of ductal carcinoma in-situ from benign micro-calcifications by dedicated breast computed tomography.
Aminololama-Shakeri S; Abbey CK; Gazi P; Prionas ND; Nosratieh A; Li CS; Boone JM; Lindfors KK
Eur J Radiol; 2016 Jan; 85(1):297-303. PubMed ID: 26520874
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of phase-contrast CT of breast tissue at conventional X-ray sources - presentation of selected findings.
Grandl S; Willner M; Herzen J; Mayr D; Auweter SD; Hipp A; Pfeiffer F; Reiser M; Hellerhoff K
Z Med Phys; 2013 Sep; 23(3):212-21. PubMed ID: 23489931
[TBL] [Abstract][Full Text] [Related]
8. Towards clinical grating-interferometry mammography.
Arboleda C; Wang Z; Jefimovs K; Koehler T; Van Stevendaal U; Kuhn N; David B; Prevrhal S; Lång K; Forte S; Kubik-Huch RA; Leo C; Singer G; Marcon M; Boss A; Roessl E; Stampanoni M
Eur Radiol; 2020 Mar; 30(3):1419-1425. PubMed ID: 31440834
[TBL] [Abstract][Full Text] [Related]
9. A practical approach to breast ductal carcinoma in situ and tumors with an extensive intraductal component.
King JM
Pathology; 1994 Apr; 26(2):90-3. PubMed ID: 8090601
[TBL] [Abstract][Full Text] [Related]
10. High-resolution 3D micro-CT imaging of breast microcalcifications: a preliminary analysis.
Willekens I; Van de Casteele E; Buls N; Temmermans F; Jansen B; Deklerck R; de Mey J
BMC Cancer; 2014 Jan; 14():9. PubMed ID: 24393444
[TBL] [Abstract][Full Text] [Related]
11. Predictors of invasive disease in patients preoperatively diagnosed with ductal carcinoma without stromal invasion, with breast magnetic resonance imaging (MRI) and ultrasound (US).
Maeda H; Hayashida T; Watanuki R; Kikuchi M; Nakashoji A; Yokoe T; Seki T; Takahashi M; Kitagawa Y
Breast Cancer; 2021 Mar; 28(2):398-404. PubMed ID: 33200381
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced cone-beam breast-CT: Analysis of optimal acquisition time for discrimination of breast lesion malignancy.
Uhlig J; Fischer U; Surov A; Lotz J; Wienbeck S
Eur J Radiol; 2018 Feb; 99():9-16. PubMed ID: 29362157
[TBL] [Abstract][Full Text] [Related]
13. The influence of clinicopathological features on the predictive accuracy of conventional breast imaging in determining the extent of screen-detected high-grade pure ductal carcinoma in situ.
Hayward L; Oeppen RS; Grima AV; Royle GT; Rubin CM; Cutress RI
Ann R Coll Surg Engl; 2011 Jul; 93(5):385-90. PubMed ID: 21943463
[TBL] [Abstract][Full Text] [Related]
14. Predictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS).
Badan GM; Piato S; Roveda D; de Faria Castro Fleury E
Eur J Radiol; 2016 Oct; 85(10):1701-1707. PubMed ID: 27666605
[TBL] [Abstract][Full Text] [Related]
15. Value of Three-Dimensional Helical CT Image-Guided Planning for Made-to-Order Lumpectomy in Breast Cancer Patients.
Uematsu T; Sano M; Homma K; Sato N
Breast J; 2004; 10(1):33-7. PubMed ID: 14717757
[TBL] [Abstract][Full Text] [Related]
16. The importance of pre-operative needle core breast biopsy results on resected tissue volume, margin status, and cosmesis.
Polat AV; Soran A; Andacoglu O; Kamali Polat A; McGuire K; Diego E; Johnson R
J BUON; 2013; 18(3):601-7. PubMed ID: 24065470
[TBL] [Abstract][Full Text] [Related]
17. Contrast-Enhanced Digital Mammography in the Surgical Management of Breast Cancer.
Ali-Mucheru M; Pockaj B; Patel B; Pizzitola V; Wasif N; Stucky CC; Gray R
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):649-655. PubMed ID: 27638679
[TBL] [Abstract][Full Text] [Related]
18. Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?
Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
Acad Radiol; 2017 Sep; 24(9):1139-1147. PubMed ID: 28506510
[TBL] [Abstract][Full Text] [Related]
19. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
[TBL] [Abstract][Full Text] [Related]
20. Preoperative breast MRI in management of patients with needle biopsy-proven ductal carcinoma in situ (DCIS).
van Bekkum S; Ter Braak BPM; Plaisier PW; van Rosmalen J; Menke-Pluijmers MBE; Westenend PJ
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1854-1860. PubMed ID: 32624292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
